A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bucur, Octavian ^a,c   Gaidos, Gabriel ^b   Yatawara, Achani ^b   Pennarun, Bodvael ^a   Rupasinghe, Chamila ^b   Roux, Jérémie ^a   Andrei, Stefan ^a   Guo, Bingqian ^b   Panaitiu, Alexandra ^b   Pellegrini, Maria ^b   Mierke, Dale F ^b   Khosravi Far, Roya ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Dartmouth College   (United States)

^c INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CASP8 PROTEIN, HUMAN; CASPASE 8; ENZYME ACTIVATOR; TNFRSF10A PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR PROTEIN;

AGONISTS; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; HELA CELL LINE; HUMAN; JURKAT CELL LINE; K-562 CELL LINE; METABOLISM; NEOPLASMS; PATHOLOGY;

APOPTOSIS; CASPASE 8; ENZYME ACTIVATION; ENZYME ACTIVATORS; HELA CELLS; HUMANS; JURKAT CELLS; K562 CELLS; NEOPLASM PROTEINS; NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84929173182     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09893     Document Type: Article

References (37)

1. Muzio M., et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827; DOI: 10.1016/S0092-8674(00)81266-0 (1996
2. Bucur O., Stancu A. L., Khosravi-Far R. & Almasan A. Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death Dis. 3, e263; DOI: 10.1038/cddis.2012.2 (2012
3. Plati J., Bucur O. & Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr. Biol. (Camb.) 3, 279-96; DOI: 10.1039/c0ib00144a (2011
4. Dumitrascu G. R. & Bucur O. Critical physiological and pathological functions of Forkhead Box O tumor suppressors. Discoveries 1, e5; DOI: 10.15190/d.2013.5 (2013
5. Kischkel F. C., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588 (1995
6. Pennarun B., et al. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim. Biophys. Acta. 1805, 123-140; DOI: 10.1016/j.bbcan.2009.11.004 (2010
7. Nicolson G. L. Update of the 1972 Singer-Nicolson Fluid-Mosaic Model of Membrane Structure. Discoveries 1, e3; DOI: 10.15190/d.2013.3 (2013
8. Pennarun B., et al. killerFLIP: a novel lytic peptide specifically inducing cancer cell death. Cell Death Dis. 4, e894; DOI: 10.1038/cddis.2013.401 (2013
9. Bucur O., et al. Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP. Apoptosis 18, 1154-1162; DOI: 10.1007/s10495-013-0880-0 (2013
10. Boatright K. M., Deis C., Denault J. B., Sutherlin D. P. & Salvesen G.S. Activation of caspases-8 and -10 by FLIP(L). Biochem. J. 382, 651-657; DOI: 10.1042/BJ20040809 (2004
11. Yu J. W., Jeffrey P. D. & Shi Y. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl. Acad. Sci. USA 106, 8169-8174; 10.1073/pnas.0812453106 (2009
12. Pop C., et al. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem. J. 433, 447-457; DOI: 10.1042/BJ20101738 (2011
13. Micheau O., et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162-45171; DOI: 10.1074/jbc.M206882200 (2002
14. Hardy J. A., Lam J., Nguyen J. T., OBrien T. & Wells J. A. Discovery of an allosteric site in the caspases. Proc. Natl. Acad. Sci. USA 101, 12461-12466; DOI: 10.1073/pnas.0404781101 (2004
15. Scheer J. M., Romanowski M. J. & Wells J. A. A common allosteric site and mechanism in caspases. Proc. Natl. Acad. Sci. USA 103, 7595-7600; DOI: 10.1073/pnas.0602571103 (2006
16. Arnold K., Bordoli L., Kopp J. & Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201; DOI: 10.1093/bioinformatics/bti770 (2006
17. Kiefer F., Arnold K., Kunzli M., Bordoli L. & Schwede T. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res. 37, D387-D392; DOI: 10.1093/nar/gkn750 (2009
18. Morris G. M., et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 19, 1639-1662; DOI: 10.1002/(SICI)1096-987X(19981115)19:143.0.CO; 2-B (1998
19. Mayer M. & Meyer B. Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. Angew. Chem. Int. Ed. 38, 1784-1788; DOI: 10.1002/(SICI)1521-3773(19990614)38:123.0.CO;2-Q (1999
20. Wang T. L. & Shaka A. J. Water suppression that works -excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. Series A. 112, 275-279 (1995
21. Reis C. R., et al. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors. Biochemistry 48, 2180-2191; DOI: 10.1021/bi801927x (2009
22. Szegezdi E., et al. Targeting AML through DR4 with a novel variant of rhTRAIL. J. Cell Mol. Med. 15, 2216-2231; DOI: 10.1111/j.1582-4934.2010.01211.x (2011
23. Albeck J. G., et al. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30, 11-25; DOI: 10.1016/j.molcel.2008.02.012 (2008
24. Bucur O., et al. Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosinekinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells. PLoS One 8, e77390; DOI: 10.1371/journal.pone.0077390 (2013
25. Singh A., et al.Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT. Mol. Biol. Cell 21, 1140-1152; DOI: 10.1091/mbc.E09-09-0795 (2010
26. SiShi L., et al. EGFR and HER2 levels are frequently elevated in colon cancer cells. Discoveries Reports 1, e1; DOI: 10.15190/drep.2014.1 (2014
27. Qiu G., Jiang J. & Liu X. S. Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis. Leuk. Res. 36, 1417-1421; DOI: 10.1016/j.leukres.2012.07.017 (2012
28. Halder A. K., Saha A. & Jha T. The role of 3D pharmacophore mapping based virtual screening for identification of novel anticancer agents: an overview. Curr. Top Med. Chem. 13, 1098-1126; DOI: 10.2174/1568026611313090009 (2013
29. Vidler L. R., et al. Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening. J. Med. Chem. 56, 8073-8088; DOI: 10.1021/jm4011302 (2013
30. Putt K. S., et al. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2, 543-550; DOI: 10.1038/nchembio814 (2006
31. Denault J. B., et al. Small molecules not direct activators of caspases. Nat. Chem. Biol. 3, 519; DOI: 10.1038/nchembio0907-519 (2007
32. Chang D. W., Xing Z., Capacio V. L., Peter M. E. & Yang X. Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22, 4132-4142; DOI: 10.1093/emboj/cdg414 (2003
33. Pettersen E. F., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612; DOI: 10.1002/jcc.20084 (2004
34. Boatright K. M., et al. A unified model for apical caspase activation. Mol. Cell 11, 529-541 (2003
35. van Dijk M., Halpin-McCormick A., Sessler T., Samali A., Szegezdi E. Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways. Cell Death Dis. 4, e702; DOI: 10.1038/cddis.2013.214 (2013
36. Pop C., Fitzgerald P., Green D. R. & Salvesen G. S. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 46, 4398-4407; DOI: 10.1021/bi602623b (2007
37. Juo P., Kuo C. J., Yuan J., Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol. 8, 1001-1008; DOI: 10.1016/S0960-9822(07)00420-4 (1998